# ZNF471

## Overview
ZNF471 is a gene that encodes the zinc finger protein 471, a member of the KRAB C2H2-type zinc finger protein family, which is the largest family of transcription factors in mammals. This protein functions primarily as a transcriptional regulator, playing a crucial role in various cellular processes such as cell differentiation, proliferation, apoptosis, and tumor suppression (Cao2018Zincfinger; Sun202019q13). Zinc finger protein 471 is characterized by its ability to bind specific DNA sequences, thereby influencing gene expression. It is predominantly active in the nucleus, where it modulates the expression of genes involved in maintaining normal cellular functions and preventing tumorigenesis (Cao2018Zincfinger). The protein's tumor suppressor function is particularly significant, as it has been shown to activate signaling pathways that promote apoptosis and inhibit cancer cell growth, such as in esophageal squamous cell carcinoma (Sun202019q13). The clinical significance of ZNF471 is underscored by its frequent inactivation through promoter hypermethylation in various cancers, making it a potential biomarker for cancer prognosis and a target for therapeutic intervention (Cao2018Zincfinger; Tao2020The).

## Function
ZNF471 is a member of the KRAB C2H2-type zinc finger protein family, which is the largest transcription factor family in mammals. These proteins are involved in regulating various physiological processes, including cell differentiation, proliferation, apoptosis, and neoplastic transformation (Sun202019q13). In healthy human cells, ZNF471 is highly expressed in normal esophageal tissues and immortalized epithelial cell lines, suggesting its role in maintaining normal cellular functions (Sun202019q13). 

ZNF471 functions as a transcription factor, binding to specific DNA sequences to regulate gene expression. It is primarily active in the nucleus, where it influences the expression of genes critical for maintaining normal cellular functions (Cao2018Zincfinger). ZNF471 has been shown to activate MAPK10/JNK3 signaling, which is important for its tumor suppressor function, by directly binding to the MAPK10/JNK3 promoter. This activation promotes apoptosis and inhibits the growth of esophageal squamous cell carcinoma (ESCC) cells (Sun202019q13). 

The protein also regulates genes related to cell adhesion, tumor suppression, apoptosis, and immunity regulation, playing a crucial role in maintaining normal cellular functions and preventing tumorigenesis (Sun202019q13). However, specific functions of ZNF471 in healthy human cells are not detailed extensively in the available literature, as the focus is primarily on its role in cancer suppression (Sun202019q13).

## Clinical Significance
ZNF471 is implicated in several cancers due to its role as a tumor suppressor gene. In gastric cancer, ZNF471 is frequently inactivated by promoter hypermethylation, leading to its downregulation. This silencing is associated with poor survival outcomes, as ZNF471 normally represses oncogenic targets such as TFAP2A and PLS3, which are involved in cell proliferation and migration (Cao2018Zincfinger). The methylation status of ZNF471 serves as an independent prognostic marker for gastric cancer, with higher methylation levels correlating with decreased mRNA expression and poor prognosis (Cao2018Zincfinger).

In breast cancer, ZNF471 is also downregulated due to promoter methylation, which is linked to poor patient survival. Its expression is inversely correlated with clinicopathologic features such as lymph node metastasis and tumor grade. ZNF471 suppresses breast cancer growth and metastasis by inhibiting the AKT and Wnt/β-catenin signaling pathways (Tao2020The).

In cervical cancer, ZNF471 is similarly silenced by promoter hypermethylation, which is associated with reduced expression and poor overall survival. ZNF471's methylation status can serve as a diagnostic and prognostic marker, distinguishing between different cancer stages and histological grades (Bhat2021ZNF471).

## Interactions
ZNF471 interacts with various proteins and nucleic acids, playing a significant role in transcriptional regulation and tumor suppression. It functions as a transcriptional repressor by binding to specific DNA motifs and recruiting co-repressors. ZNF471 contains a KRAB domain at its N-terminal, which interacts with KRAB-Interacting Protein 1 (KAP1). This interaction is crucial for its repressive function, as KAP1 acts as a scaffold to recruit other proteins, including heterochromatin protein 1 isoforms, histone deacetylases, and SET Domain Bifurcated 1, forming a heterochromatin environment that leads to transcriptional repression (Cao2018Zincfinger).

ZNF471 also binds directly to the promoter regions of specific genes, such as MAPK10/JNK3 in esophageal squamous cell carcinoma (ESCC), activating their transcription. This binding was confirmed through chromatin immunoprecipitation (ChIP) assays, which demonstrated ZNF471's role in activating MAPK10/JNK3 signaling, leading to apoptosis and growth inhibition in ESCC cells (Sun202019q13). In gastric cancer, ZNF471 binds to the promoters of oncogenic targets TFAP2A and PLS3, repressing their expression through the recruitment of KAP1 and the enrichment of the H3K9me3 epigenetic marker (Cao2018Zincfinger). These interactions highlight ZNF471's role in modulating gene expression and its potential as a tumor suppressor.


## References


[1. (Bhat2021ZNF471) Samatha Bhat, Shama Prasada Kabekkodu, Divya Adiga, Rayzel Fernandes, Vaibhav Shukla, Poonam Bhandari, Deeksha Pandey, Krishna Sharan, and Kapaettu Satyamoorthy. Znf471 modulates emt and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer. Cell Biology and Toxicology, 37(5):731–749, February 2021. URL: http://dx.doi.org/10.1007/s10565-021-09582-4, doi:10.1007/s10565-021-09582-4. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10565-021-09582-4)

[2. (Cao2018Zincfinger) Lei Cao, Shiyan Wang, Yanquan Zhang, Ka-Chun Wong, Geicho Nakatsu, Xiaohong Wang, Sunny Wong, Jiafu Ji, and Jun Yu. Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic pls3 and tfap2a. Oncogene, 37(26):3601–3616, April 2018. URL: http://dx.doi.org/10.1038/s41388-018-0220-5, doi:10.1038/s41388-018-0220-5. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-018-0220-5)

[3. (Sun202019q13) Ran Sun, Tingxiu Xiang, Jun Tang, Weiyan Peng, Jie Luo, Lili Li, Zhu Qiu, Yiqing Tan, Lin Ye, Min Zhang, Guosheng Ren, and Qian Tao. 19q13 krab zinc-finger protein znf471 activates mapk10/jnk3 signaling but is frequently silenced by promoter cpg methylation in esophageal cancer. Theranostics, 10(5):2243–2259, 2020. URL: http://dx.doi.org/10.7150/thno.35861, doi:10.7150/thno.35861. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.35861)

[4. (Tao2020The) Chunfang Tao, Juan Luo, Jun Tang, Danfeng Zhou, Shujun Feng, Zhu Qiu, Thomas C. Putti, Tingxiu Xiang, Qiao Tao, Lili Li, and Guosheng Ren. The tumor suppressor zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting akt and wnt/β-catenin signaling. Clinical Epigenetics, November 2020. URL: http://dx.doi.org/10.1186/s13148-020-00959-6, doi:10.1186/s13148-020-00959-6. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-020-00959-6)